Rhythm Pharmaceuticals
Cherry C. Bernard has over a decade of experience in regulatory operations and publishing within the pharmaceutical industry. Currently serving as the Director of Regulatory Operations at Rhythm Pharmaceuticals Inc. since August 2020, Cherry has previously held positions as Associate Director and Senior Manager of Regulatory Publishing at the same company. Prior experience includes the role of Publishing Manager at PRA Health Sciences from November 2016 to July 2020, and serving as a Sr. Regulatory Affairs Specialist on a contract basis at Takeda Oncology from September 2012 to November 2016.
This person is not in any teams
Rhythm Pharmaceuticals
1 followers
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity.